Latest News
Medtronic receives FDA clearance for LigaSure RAS Maryland instrument on Hugo system
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery syst...
WHO identifies SynAct Pharma's resomelagon among six dengue drug candidates
16 September 2026 - Clinical-stage biotechnology company SynAct Pharma AB (STO:SYNACT) said on Wednesday that the World Health Organization (WHO) has identified resomelagon as one of six dengue therapeutic candidates with evidence supporting further ...
Japan approves subcutaneous Leqembi formulation for early Alzheimer's disease
16 September 2026 - Swedish biopharmaceutical company BioArctic AB (STO: BIOA-B) on Wednesday shared that its partner Eisai Co Ltd (TYO: 4523) has received Japanese approval for the subcutaneous autoinjector formulation of Leqembi for early Alzheimer...
Japan approves Lundbeck's eptinezumab for preventive migraine treatment
16 September 2026 - Danish biopharmaceutical company H. Lundbeck A/S (CPH: HLUN-B) said on Wednesday it has received marketing authorisation from Japan's Ministry of Health, Labour and Welfare for eptinezumab for the prevention of migraine attac...
Jubilant Therapeutics reports preliminary clinical data from Phase 1/2 study in myeloproliferative neoplasms at SOHO 2026
16 September 2026 - Jubilant Therapeutics Inc, a US-based clinical-stage biopharmaceutical company advancing precision therapies for hematological malignancies, announced on Tuesday the presentation of the first clinical data from its ongoing Phase 1...